AAAAAA
Results:
1-18
|
Results: 18
Authors:
VANDENBENT MJ
HILKENS PHE
SMITT PAES
VANRAAIJVANDENAARSSEN VJM
BONTENBAL M
VERWEIJ J
Citation: Mj. Vandenbent et al., LHERMITTES SIGN FOLLOWING CHEMOTHERAPY WITH DOCETAXEL, Neurology, 50(2), 1998, pp. 563-564
Authors:
BONTENBAL M
ANDERSSON M
WILDIERS J
COCCONI G
JASSEM J
PARIDAENS R
ROTMENSZ N
SYLVESTER R
MOURIDSEN HT
KLIJN JGM
VANOOSTEROM AT
Citation: M. Bontenbal et al., DOXORUBICIN VS EPIRUBICIN, REPORT OF A 2ND-LINE RANDOMIZED PHASE-II PHASE-III STUDY IN ADVANCED BREAST-CANCER/, British Journal of Cancer, 77(12), 1998, pp. 2257-2263
Authors:
BONTENBAL M
FOEKENS JA
LAMBERTS SWJ
DEJONG FH
VANPUTTEN WLJ
BRAUN HJ
BURGHOUTS JTM
VANDERLINDEN GHM
KLIJN JGM
Citation: M. Bontenbal et al., FEASIBILITY, ENDOCRINE AND ANTITUMOR EFFECTS OF A TRIPLE ENDOCRINE THERAPY WITH TAMOXIFEN, A SOMATOSTATIN ANALOG AND AN ANTIPROLACTIN IN POSTMENOPAUSAL METASTATIC BREAST-CANCER - A RANDOMIZED STUDY WITH LONG-TERM FOLLOW-UP, British Journal of Cancer, 77(1), 1998, pp. 115-122
Authors:
PICCART MJ
KLIJN J
PARIDAENS R
NOOIJ M
MAURIAC L
COLEMAN R
BONTENBAL M
AWADA A
SELLESLAGS J
VANVRECKEM A
VANGLABBEKE M
Citation: Mj. Piccart et al., CORTICOSTEROIDS SIGNIFICANTLY DELAY THE ONSET OF DOCETAXEL-INDUCED FLUID RETENTION - FINAL RESULTS OF A RANDOMIZED STUDY OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER INVESTIGATIONAL DRUG BRANCH FOR BREAST-CANCER, Journal of clinical oncology, 15(9), 1997, pp. 3149-3155
Authors:
TILANUSLINTHORST MMA
OBDEIJN AIM
BONTENBAL M
OUDKERK M
Citation: Mma. Tilanuslinthorst et al., MRI IN PATIENTS WITH AXILLARY METASTASES OF OCCULT BREAST-CARCINOMA, Breast cancer research and treatment, 44(2), 1997, pp. 179-182
Authors:
DEWIT R
VERWEIJ J
BONTENBAL M
KRUIT WHJ
SEYNAEVE C
SCHMITZ PIM
STOTER G
Citation: R. Dewit et al., ADVERSE EFFECT ON BONE-MARROW PROTECTION OF PRECHEMOTHERAPY GRANULOCYTE-COLONY-STIMULATING FACTOR SUPPORT, Journal of the National Cancer Institute, 88(19), 1996, pp. 1393-1398
Authors:
KLIJN JGM
SETYONOHAN B
BONTENBAL M
SEYNAEVE C
FOEKENS J
Citation: Jgm. Klijn et al., NOVEL ENDOCRINE THERAPIES IN BREAST-CANCER, Acta oncologica, 35(5), 1996, pp. 30-37
Authors:
DEVRIES EGE
RODENHUIS S
SCHOUTEN HC
HUPPERETS PSGJ
DOLSMA WV
LEBESQUE JV
BLIJHAM GH
BONTENBAL M
MULDER NH
Citation: Ege. Devries et al., PHASE-II STUDY OF INTENSIVE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PATIENTS IN COMPLETE REMISSION OF DISSEMINATED BREAST-CANCER, Breast cancer research and treatment, 39(3), 1996, pp. 307-313
Authors:
DEGREEF GE
SCHIPPERUS M
DEWINTER F
CORNELISSEN JJ
BONTENBAL M
VANTVEER MB
LOWENBERG B
Citation: Ge. Degreef et al., THE NUMBER OF CD34-BLOOD BEFORE LEUKAPHERESIS IS PREDICTIVE FOR THE VOLUME TO BE PROCESSED( CELLS IN THE PERIPHERAL), Blood, 88(10), 1996, pp. 3662-3662
Authors:
SCHIPPERUS MR
DEGREEF GE
DEWINTER F
BONTENBAL M
LOWENBERG B
Citation: Mr. Schipperus et al., CD34-POSITIVE CELL YIELD OF A PERIPHERAL-BLOOD PROGENITOR-CELL HARVEST IS DEPENDENT ON THE PATIENTS DIAGNOSIS, Blood, 88(10), 1996, pp. 1598-1598
2ND-LINE CHEMOTHERAPY WITH LONG-TERM LOW-DOSE ORAL ETOPOSIDE IN PATIENTS WITH ADVANCED BREAST-CANCER
Authors:
BONTENBAL M
PLANTING AST
VERWEIJ J
DEWIT R
KRUIT WHJ
STOTER G
KLIJN JGM
Citation: M. Bontenbal et al., 2ND-LINE CHEMOTHERAPY WITH LONG-TERM LOW-DOSE ORAL ETOPOSIDE IN PATIENTS WITH ADVANCED BREAST-CANCER, Breast cancer research and treatment, 34(2), 1995, pp. 185-189
Authors:
VANGERVEN JMA
MOLL JWB
VANDENBENT MJ
BONTENBAL M
VANDERBURG MEL
VERWEIJ J
VECHT CJ
Citation: Jma. Vangerven et al., PACLITAXEL (TAXOL) INDUCES CUMULATIVE MILD NEUROTOXICITY, European journal of cancer, 30A(8), 1994, pp. 1074-1077
Authors:
VANDERGAAST A
BONTENBAL M
PLANTING AST
KOK TC
SPLINTER TAW
Citation: A. Vandergaast et al., PHASE-II STUDY OF CARBOPLATIN AND ETOPOSIDE AS A FIRST-LINE REGIMEN IN PATIENTS WITH METASTATIC BREAST-CANCER, Annals of oncology, 5(9), 1994, pp. 858-860
Authors:
LOGMANS A
MOUS HVH
BONTENBAL M
BEERMAN H
VANLENT M
Citation: A. Logmans et al., RESULTS OF CURETTAGE FOR POSTMENOPAUSAL VAGINAL BLEEDING IN WOMEN TREATED WITH TAMOXIFEN AND MEGESTROL-ACETATE FOR PROGRESSIVE METASTATIC BREAST-CARCINOMA, European journal of obstetrics, gynecology, and reproductive biology, 56(3), 1994, pp. 173-176
Authors:
VANLEEUWEN FE
BENRAADT J
COEBERGH JWW
KIEMENEY LALM
GIMBRERE CHF
OTTER R
SCHOUTEN LJ
DAMHUIS RAM
BONTENBAL M
DIEPENHORST FW
VANDENBELTDUSEBOUT AW
VANTINTEREN H
Citation: Fe. Vanleeuwen et al., RISK OF ENDOMETRIAL CANCER AFTER TAMOXIFEN TREATMENT OF BREAST-CANCER, Lancet, 343(8895), 1994, pp. 448-452
Authors:
FOEKENS JA
PORTENGEN H
LOOK MP
VANPUTTEN WLJ
THIRION B
BONTENBAL M
KLIJN JGM
Citation: Ja. Foekens et al., RELATIONSHIP OF PS2 WITH RESPONSE TO TAMOXIFEN THERAPY IN PATIENTS WITH RECURRENT BREAST-CANCER, British Journal of Cancer, 70(6), 1994, pp. 1217-1223
Authors:
KLIJN JGM
BERNS EMJJ
BONTENBAL M
FOEKENS J
Citation: Jgm. Klijn et al., CELL BIOLOGICAL FACTORS ASSOCIATED WITH THE RESPONSE OF BREAST-CANCERTO SYSTEMIC TREATMENT, Cancer treatment reviews, 19, 1993, pp. 45-63
Authors:
VANOOIJEN B
BONTENBAL M
HENZENLOGMANS SC
KOPER PCM
Citation: B. Vanooijen et al., AXILLARY NODAL METASTASES FROM AN OCCULT PRIMARY CONSISTENT WITH BREAST-CARCINOMA, British Journal of Surgery, 80(10), 1993, pp. 1299-1300
Risultati:
1-18
|